BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25074869)

  • 1. Intravenous proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: determining statistical equivalence according to evidence-based methods.
    Messori A; Fadda V; Maratea D; Gatto R; Trippoli S; De Rosa M; Marinai C
    Int J Clin Pharmacol Ther; 2014 Oct; 52(10):825-9. PubMed ID: 25074869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.
    Zhou X; Fang H; Xu J; Chen P; Hu X; Chen B; Wang H; Hu C; Xu Z
    BMC Gastroenterol; 2019 Nov; 19(1):193. PubMed ID: 31752703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Histamine
    Hammond DA; Kathe N; Shah A; Martin BC
    Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.
    Reynolds PM; MacLaren R
    Pharmacotherapy; 2019 Mar; 39(3):408-420. PubMed ID: 30101529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
    Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
    Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
    Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
    Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis.
    Barkun AN; Bardou M; Pham CQ; Martel M
    Am J Gastroenterol; 2012 Apr; 107(4):507-20; quiz 521. PubMed ID: 22290403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.
    Krag M; Perner A; Wetterslev J; Wise MP; Hylander Møller M
    Intensive Care Med; 2014 Jan; 40(1):11-22. PubMed ID: 24141808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients.
    Jung R; MacLaren R
    Ann Pharmacother; 2002 Dec; 36(12):1929-37. PubMed ID: 12452757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
    Tofil NM; Benner KW; Fuller MP; Winkler MK
    J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress Ulcer Prophylaxis.
    Barletta JF; Bruno JJ; Buckley MS; Cook DJ
    Crit Care Med; 2016 Jul; 44(7):1395-405. PubMed ID: 27163192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU.
    Boyd C; Hassig T; MacLaren R
    Pharmacotherapy; 2021 Oct; 41(10):820-827. PubMed ID: 34478588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton Pump Inhibitors Versus Histamine-2 Receptor Antagonists Likely Increase Mortality in Critical Care: An Updated Meta-Analysis.
    Lee TC; Goodwin Wilson M; Lawandi A; McDonald EG
    Am J Med; 2021 Mar; 134(3):e184-e188. PubMed ID: 32931766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress ulcer prophylaxis in critical illness: a Canadian survey.
    Shears M; Alhazzani W; Marshall JC; Muscedere J; Hall R; English SW; Dodek PM; Lauzier F; Kanji S; Duffett M; Barletta J; Alshahrani M; Arabi Y; Deane A; Cook DJ
    Can J Anaesth; 2016 Jun; 63(6):718-24. PubMed ID: 26911559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological interventions for stress ulcer prophylaxis in critically ill patients: a mixed treatment comparison network meta-analysis and a recursive cumulative meta-analysis.
    Sridharan K; Sivaramakrishnan G; Gnanaraj J
    Expert Opin Pharmacother; 2018 Feb; 19(2):151-158. PubMed ID: 29271262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.
    ; Young PJ; Bagshaw SM; Forbes AB; Nichol AD; Wright SE; Bailey M; Bellomo R; Beasley R; Brickell K; Eastwood GM; Gattas DJ; van Haren F; Litton E; Mackle DM; McArthur CJ; McGuinness SP; Mouncey PR; Navarra L; Opgenorth D; Pilcher D; Saxena MK; Webb SA; Wiley D; Rowan KM
    JAMA; 2020 Feb; 323(7):616-626. PubMed ID: 31950977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review.
    Krag M; Perner A; Wetterslev J; Møller MH
    Acta Anaesthesiol Scand; 2013 Aug; 57(7):835-47. PubMed ID: 23495933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials.
    Alshamsi F; Belley-Cote E; Cook D; Almenawer SA; Alqahtani Z; Perri D; Thabane L; Al-Omari A; Lewis K; Guyatt G; Alhazzani W
    Crit Care; 2016 May; 20(1):120. PubMed ID: 27142116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress ulcer prophylaxis in critically ill children: Protocol for a systematic review.
    Jensen MM; Marker S; Do HQ; Perner A; Møller MH
    Acta Anaesthesiol Scand; 2019 Aug; 63(7):966-972. PubMed ID: 30907441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessing the Use of Proton Pump Inhibitors and Histamine-2 Antagonists in Critically Ill Children: A Systematic Review and Meta-Analysis.
    Yao DWJ; Ong C; Eales NM; Sultana R; Wong JJ; Lee JH
    J Pediatr; 2021 Jan; 228():164-176.e7. PubMed ID: 32916144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.